Although many questions remain to be answered, such as how olverembatinib regulates CD36 or other genes involved in lipid metabolism, the results from our study provide a new direction for revealing MOAs of TKIs in SDH-deficient GIST. The gene discussed is CD36; the disease is gastrointestinal stromal tumor.